Answers are grounded in this paper and cite their sources.
Quasi-experimental intervention enhanced endometrial thickness and gene expression in patients with Asherman's syndrome, suggesting new IVF approaches.
Context Thin endometrium with Asherman's syndrome is a challenge in in vitro fertilisation, as patients cannot conceive even if the embryo is well. Aims This study aimed to regenerate thin endometria unresponsive to treatments, using autologous endometrial cells and acellular amnion bilayer as a womb patch. Methods This preliminary quasi-experimental study investigated thin endometria before and after intervention with an amnion bilayer (AB) and AB with self-endometrial cells (AB+Cells). Patients were IVF candidates with oligomenorrhea, endometrial thickness (EMT) Key results Average EMT increased significantly from 5.03±0.95mm to 6.75±1.39mm after AB, and further to 7.33±1.92mm after AB+Cells. Cell density was significantly higher after AB+Cells. The histoarchitecture after AB+Cells developed into a complex tubular system, and E-cadherin and oestrogen receptor alpha (ER-α) was detected. Homeobox A10 (HOXA10 ) expression increased significantly, up to 4.5-fold after AB+Cells treatment compared with before treatment (P =0.01), while leukaemia inhibitory factor (LIF ) and osteopontin (SPP1 ) levels also increased, but not significantly. Significant changes in gene expression and cell populations were observed, with improvements in receptivity genes. Conclusions Patients with thin endometria showed improvement in EMT, histoarchitecture, and receptivity genes after AB and AB+Cells intervention. Implications The study demonstrates the potential of using a 3D amnion bilayer scaffold with endometrial cells to improve endometrial regeneration.
No takes yet. Share an insight, caveat, or question.
Wiweko et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: